Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy-Reference-Cited by-同舟云学术

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Published:2015-09-28 Issue:2 Volume:48 Page:93-98
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Gaines Hans¹²³,Albert Jan⁴⁵⁶,Axelsson Maria¹,Berglund Torsten¹,Gisslén Magnus⁶⁷,Sönnerborg Anders³⁵⁶⁸,Blaxhult Anders⁹,Bogdanovic Gordana⁵,Brytting Maria¹,Carlander Christina⁶¹⁰,Flamholc Leo⁶¹¹,Follin Per¹²,Haggar Axana¹³,Hagstam Per¹⁴,Johansson Marcus¹⁵,Navér Lars⁶¹⁶¹⁷,Persson blom Jenny¹⁸,Samuelson Agneta⁵,Ström Helena¹³,Sundqvist Martin¹⁹,Svedhem johansson Veronica³,Tegmark wisell Karin¹,Tegnell Anders¹,Thorstensson Rigmor¹

Affiliation:

1. Public Health Agency of Sweden, Solna,

2. Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm,

3. Department of Infectious Diseases, Karolinska University Hospital, Stockholm,

4. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm,

5. Department of Clinical Microbiology, Karolinska University Hospital, Stockholm,

6. Swedish Reference Group for Antiviral Therapy, Stockholm,

7. Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg,

8. Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm,

9. Department of Infectious Diseases, Södersjukhuset Venhälsan, Stockholm,

10. Clinic of Infectious Diseases, County Hospital of Västmanland, Västerås,

11. Department of Infectious Diseases, University of Lund, Skåne University Hospital, Malmö,

12. Department of Communicable Disease Control and Prevention, Region Västra Götaland, Gothenburg,

13. National Board of Health and Welfare, Stockholm,

14. Department of Communicable Disease Control and Prevention, Skåne, Malmö,

15. Department of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital, Kalmar,

16. Department of Pediatrics, Karolinska University Hospital, Stockholm,

17. Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm,

18. Swedish Work Environment Authority, Stockholm, and

19. Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/23744235.2015.1089593

Reference59 articles.

1. ANTIBODY RESPONSE IN PRIMARY HUMAN IMMUNODEFICIENCY VIRUS INFECTION

2. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure

3. Viral dynamics in primary HIV-1 infection

4. Gaines H, Thorstensson R, Lindbäck S, Biberfeld G. [HIV testing.] Smittskydd 1995:3–5 (in Swedish).

5. Folkhelseinstituttet. Hivinfeksjon/Aids – veileder for helsepersonell. Accessed October 9, 2014. Available from: http://www.fhi.no/artikler/?id = 82756

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory diagnosis of HIV: a contemporary overview in the Australian context;Pathology;2023-08

2. Antiretroviral treatment for HIV infection: Swedish recommendations 2019;Infectious Diseases;2020-01-11

3. What Is New in Point-of-Care Testing?;Point of Care: The Journal of Near-Patient Testing & Technology;2018-03

4. Factors associated with loss to follow-up after occupational HIV exposure in Cape Town, South Africa: a retrospective cohort study;AIDS Research and Therapy;2017-04-21

5. Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis;BMC Infectious Diseases;2016-11-29